Entity Common Stock, Shares Outstanding of Drugs Made In America Acquisition Corp. from 28 Mar 2025 to 18 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Drugs Made In America Acquisition Corp. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 28 Mar 2025 to 18 Nov 2025.
  • Drugs Made In America Acquisition Corp. Entity Common Stock, Shares Outstanding for the quarter ending 18 Nov 2025 was 33,517,143.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)

Drugs Made In America Acquisition Corp. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 33,517,143 18 Nov 2025 10-Q 18 Nov 2025 2025 Q3
Q2 2025 33,517,143 20 May 2025 10-Q 20 May 2025 2025 Q1
Q1 2025 33,517,143 28 Mar 2025 10-K 31 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.